ArticleMultiple sclerosis journal - experimental, translational and clinical
Safety and efficacy of extended versus standard interval dosing of anti-CD20 therapy in multiple sclerosis - A meta-analysis.
Mahmoud Elkhooly et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.